首页> 美国卫生研究院文献>Journal of Kidney Cancer and VHL >The Pathology and Molecular Genetics of Sarcomatoid Renal Cell Carcinoma: A Mini-Review
【2h】

The Pathology and Molecular Genetics of Sarcomatoid Renal Cell Carcinoma: A Mini-Review

机译:肉瘤样肾细胞癌的病理学和分子遗传学:简要审查。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Sarcomatoid renal cell carcinoma is a highly aggressive tumor. It is not a distinct histologic entity as it can be found in any subtypes of renal cell carcinoma. Recent molecular and genetic evidence suggest that sarcomatoid component is transformed from a common progenitor of the associated renal cell carcinoma, and the TP53 gene plays a pivotal role in this process. The presence of sarcomatoid carcinoma indicates poor prognosis, which also correlates with the amount of the sarcomatoid component. Therefore, the presence and quantity of sarcomatoid component should be reflected in pathology reports. However, pathology reporting seems to vary among laboratories prompting the need for a unified reporting system. We propose a pathology reporting system similar to that of transformed follicular lymphoma that is consistent with the molecular pathogenesis to ensure uniform reporting.
机译:肉瘤样肾细胞癌是高度侵袭性的肿瘤。它不是明显的组织学实体,因为它可以在任何肾细胞癌亚型中发现。最近的分子和遗传证据表明,肉瘤样成分从相关肾细胞癌的共同祖细胞转化而来,而TP53基因在此过程中起着关键作用。肉瘤样癌的存在表明预后不良,这也与肉瘤样成分的量有关。因此,肉瘤样成分的存在和数量应在病理报告中反映出来。但是,实验室之间的病理报告似乎有所不同,因此需要统一的报告系统。我们提出了与转化的滤泡性淋巴瘤相似的病理报告系统,该系统与分子发病机制相符,以确保报告的一致性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号